WeVote
Log In

Bill

Bill

SF 3854

Pharmacy benefit manager requirement clarification

2025-2026 Regular Session Introduced by Alice Mann

Minnesota bill clarifies pharmacy benefit manager regulatory requirements to potentially increase prescription transparency and reduce medication costs for consumers and healthcare systems.

Referred to State and Local Government
#government-state
0
WeVote Research Nonpartisan
Bill Summary · SF 3854

Legislative bill overview

SF 3854 clarifies requirements for pharmacy benefit managers (PBMs) operating in Minnesota, establishing or reinforcing standards for how these intermediaries between insurers, pharmacies, and patients must conduct business. The bill was introduced by Senator Alice Mann and referred to the State and Local Government Committee for consideration.

Why is this important

PBMs significantly influence prescription drug costs and pharmacy operations, affecting both consumer medication access and the viability of independent pharmacies. Clarifying regulatory requirements can impact drug pricing transparency, pharmacy reimbursement rates, and ultimately what Minnesotans pay for medications—making this relevant to healthcare costs statewide.

Potential points of contention

  • PBM industry opposition: National pharmacy benefit managers may resist expanded requirements as cost-increasing or operationally burdensome
  • Scope ambiguity: Unclear whether clarifications apply only to PBMs directly licensed in Minnesota or those operating across state lines, affecting enforcement
  • Insurance premium impacts: Stricter PBM regulations could increase costs for insurers, potentially raising premiums for consumers unless offset by drug cost savings

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.